Prescient Healthcare Group Acquires Strategic North

Acquisition to enhance depth, breadth and value of services offered to pharmaceutical and biotech clients of both organizations

Prescient, a biopharma product and portfolio strategy firm, announced Tuesday the recent acquisition of Strategic North, a global commercial strategy consultancy that partners with a wide range of pharmaceutical companies to help them better understand how their customers make decisions in order to unlock the full potential of their brands.

To continue reading,
become a free ALM digital reader

Benefits include:

  • Complimentary access to Consulting Magazine Online and digital edition
  • Bi-monthly digital newsletter delivered to your inbox
  • 1 free article* every 30 days to Consulting Magazine's sister publications
  • Exclusive discounts on events and publications produced by ALM

*May exclude premium content